Vivimed Labs has informed that the Board of Directors of the Company at its meeting held on January 11, 2016, has approved, resolved, and taken note of the sub division proposal of Company’s Equity Shares from the existing face value of Rs 10 per Equity Share to Rs 2 per Equity Share subject to the approval of Company’s shareholders, which is proposed to be obtained through Postal Ballot & E-Voting, to conduct Postal Ballot & E-Voting for seeking approval of members for the above matter, and has taken on record the resignation of Srinivas Chidambaram from the Board of Directors of the Company and Consequently reconstituted the Audit Committee.
The above information is a part of company’s filings submitted to BSE.
